Skip to main content

Table 5 Agreement between PET/CT results and pathology as regard T staging

From: Delayed post-diuretic 18F-FDG PET/CT: can it help in determination of the best clinical decision for muscle invasive UB cancer patients?

 

PET/CT staging

Kappa (CI*)

T2

T3

T4a

N

%

N

%

N

%

Pathological staging

T2

5

100.0

0

0

0

0

0.838 (0.723 to 0.953)

T3

0

0

4

100.0

0

0

T3B

0

0

0

0

1

50.0

T4a

0

0

0

0

0

0

T4B

0

0

0

0

1

50.0